Navigation Links
The onchocerciasis parasite showing signs of resistance
Date:1/31/2008

Onchocerciasis is an infection caused by Onchocerca volvulus, a parasite nematode worm transmitted to humans by a species of black fly of the Simulium genus whose larvae develop in fast-flowing rivers. Infected subjects suffer not only from severe skin lesions but also eye damage that can lead to irreversible loss of sight, hence the name river blindness. A huge majorityy -- 99% -- of the 37 million people infected by the parasite live in SubSaharan Africa. Ivermectin, a medicine capable of killing the parasite embryos (the microfilariae) circulating in the organism of patients and temporarily interrupting the nematodes reproduction, is the only treatment used for onchocerciasis control. Since 1995, the African Programme for Onchocerciasis Control (APOC) has been covering 19 of the continents 28 countries hit by the disease. Access to this treatment is possible for 70 million people and has significantly diminished the onchocerciasis-induced morbidity. However, the doubling of cases of infection in certain communities of Ghana between 2000 and 2005, in spite of annual treatments, created fear of the emergence of ivermectin-resistant strains. Such apprehension appears particularly justified in that a high degree of therapeutic cover is achieved during mass distribution campaigns and hence only a tiny part of the parasite population targeted remains unexposed to drug treatment pressure.

Since 1994, a team of IRD researchers, working jointly with Cameroon researchers and others from McGill University of Montreal, has been monitoring a cohort of Cameroon patients benefiting from repeated treatments with ivermectin. Regular parasite sampling from these subjects was performed over a 13-year period in order to determine the changes in the genetic structure of Onchocerca volvulus populations. Each occasion involved measurement of the genotype frequency of heterozygotes and homozygotes for the gene coding β-tubulin, a protein involved in the organiz
'/>"/>

Contact: Gregory Flechet
fichesactu@paris.ird.fr
33-014-803-7607
Institut de Recherche Pour le Dveloppement
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists Map Elephantiasis Parasites Genome
2. Summer Temperatures Linger, Extend Threat of Parasites
3. Parasites a key to the decline of red colobus monkeys in forest fragments
4. To fight disease, animals, like plants, can tolerate parasites
5. Study of malaria parasites reveals new parasitic states
6. Infection With Common Parasite Raises Schizophrenia Risk
7. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
8. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
9. Clinical Study Published Showing Benefits of Glue Used in Facelift Surgery
10. Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
11. The Organic Trade Association Hails Preliminary Research Findings Showing Nutritional Benefits of Organic Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...Scientists have developed a computer test which th... computer programme is modelled on the human brain...like humans. The system, was developed at the Uni...er Liddle, a psychiatrist specialising in brain im...
...Concerned about the increasing number of partial-l...are proposing an external regulator be appointed t...rding to a survey conducted at the Mount Sinai Hos...post-surgical care, when a 57-year-old man died af...
...Psychologists in Ohio have shown that people who h...eir immune systems.//Regular sex could help to war...ntists can evaluate how healthy our immune systems...ulin A (IgA), an antigen found in saliva and mucos...
...The cure for the common cold remains as elusive as...cently that the first drug aimed at treating the c...ot be approved. In a unanimous decision, the Food...on anti-viral drugs said there were too many quest...
Other Medicine News:
(Date:8/19/2008)...., Aug. 19 /- Particle Sciences Inc. ... polymers) development and,pilot production capabi...rusion and injection molding line. The core of the...ding extruder and Nissei 20T injection,molder, ena...lymeric,devices. This addition gives Particle Scie...
(Date:8/19/2008)...nn., Aug. 19 /- VION,PHARMA...y that it had,entered into an agreement with the D...y Oncology (the "HOVON") to conduct a clinical tri...h standard remission-induction,therapy in patients...enous,leukemia (AML) and high-risk myelodysplasia ...
(Date:8/18/2008)...g. 18 /- The next time you consider p...t might be worth counting sheep,instead. A senior ... San,Diego, Calif. has found evidence that taking ...skin cancer., Daniel F. Kripke, M.D.,s article, b...g pills and cancer, has just been published in the...
(Date:8/18/2008)...rael, August 18 /- Oramed,P....oramed.com ), a developer,of oral delivery system...en,Label Study to Assess the Safety, Pharmacokinet...sulin Formulations in Healthy,Subjects," has been ...l,Meeting of the European Association for the Stud...
Breaking Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Prescription Sleeping Pill Use Tied to Cancer 2Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 1Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 3Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 4Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 5For migrating sparrows kids have a compass but adults have the map 1116 1For migrating sparrows kids have a compass but adults have the map 1116 2Breastfeeding boost IQ in infants with helpful genetic variant 1115 1Breastfeeding boost IQ in infants with helpful genetic variant 1115 22007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 12007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 2
Angled for temporal approach. Solid 14 mm blades. Dull finish.
Solid 4 mm blades. Locking thumb. Dull finish. Holes in bar decrease weight of speculum.
Open 11 mm blades. Polished finish.
Closed wire 5 mm blade with a wing tip twist giving the surgeon better on-axis accessibility.
Medicine Products: